Sing Investments & Finance Limited (SGX:S35)
1.330
0.00 (0.00%)
At close: Aug 8, 2025, 5:00 PM SGT
CTI BioPharma Balance Sheet
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 281.24 | 195.3 | 375.63 | 243.06 | 298.62 | 370.62 | Upgrade |
Long-Term Investments | 434.42 | 440.25 | 456.87 | 341.03 | 369.53 | 289.28 | Upgrade |
Loans & Lease Receivables | 2,635 | 2,669 | 2,451 | 2,406 | 2,141 | 2,078 | Upgrade |
Other Receivables | 6.79 | 5.77 | 10.72 | 3.54 | 2.41 | 3.42 | Upgrade |
Property, Plant & Equipment | 19.42 | 19.89 | 21.76 | 22.85 | 23.61 | 24.69 | Upgrade |
Restricted Cash | 82.33 | 82.79 | 75.03 | 69.59 | 60.85 | 59.84 | Upgrade |
Other Current Assets | - | - | - | 1.55 | 2.46 | 2.73 | Upgrade |
Long-Term Deferred Tax Assets | - | 0.39 | 0.53 | 1.26 | - | - | Upgrade |
Other Long-Term Assets | 29.76 | 30.04 | 21.05 | 21.43 | 21.81 | 22.19 | Upgrade |
Total Assets | 3,489 | 3,443 | 3,412 | 3,110 | 2,920 | 2,850 | Upgrade |
Interest Bearing Deposits | 2,962 | 2,928 | 2,906 | 2,601 | 2,293 | 2,279 | Upgrade |
Total Deposits | 2,962 | 2,928 | 2,906 | 2,601 | 2,293 | 2,279 | Upgrade |
Accrued Expenses | 0.18 | 0.18 | 0.18 | 22.14 | 15.35 | 19.11 | Upgrade |
Current Portion of Long-Term Debt | - | 0.02 | 0.02 | 55.8 | 136.89 | 3.66 | Upgrade |
Current Portion of Leases | - | - | - | 0.03 | 0.03 | 0.03 | Upgrade |
Long-Term Debt | 1.02 | 1.31 | 1.96 | 1.26 | 55.03 | 148.18 | Upgrade |
Long-Term Leases | - | - | - | 0.1 | 0.02 | 0.05 | Upgrade |
Long-Term Unearned Revenue | - | - | - | 0.21 | 2.91 | 3.42 | Upgrade |
Current Income Taxes Payable | 8.28 | 7.61 | 6.78 | 6.94 | 6.1 | 4.52 | Upgrade |
Other Current Liabilities | - | - | - | 0.63 | 0.63 | 0.62 | Upgrade |
Long-Term Deferred Tax Liabilities | 1.21 | - | - | - | 1.97 | 3.67 | Upgrade |
Other Long-Term Liabilities | 41.37 | 45.91 | 60.84 | 6.56 | 1.95 | 1.02 | Upgrade |
Total Liabilities | 3,014 | 2,983 | 2,976 | 2,695 | 2,514 | 2,463 | Upgrade |
Common Stock | 180.01 | 180.01 | 180.01 | 180.01 | 180.01 | 180.01 | Upgrade |
Retained Earnings | - | 283.78 | 261.63 | 244.18 | 219.59 | 193.69 | Upgrade |
Comprehensive Income & Other | 294.56 | -3.39 | -5.18 | -9.37 | 6.17 | 13.77 | Upgrade |
Shareholders' Equity | 474.57 | 460.4 | 436.46 | 414.82 | 405.77 | 387.46 | Upgrade |
Total Liabilities & Equity | 3,489 | 3,443 | 3,412 | 3,110 | 2,920 | 2,850 | Upgrade |
Total Debt | 1.02 | 1.33 | 1.98 | 57.19 | 191.97 | 151.92 | Upgrade |
Net Cash (Debt) | 280.23 | 193.97 | 373.65 | 185.87 | 106.65 | 218.7 | Upgrade |
Net Cash Growth | 48.18% | -48.09% | 101.03% | 74.28% | -51.23% | -19.81% | Upgrade |
Net Cash Per Share | 1.19 | 0.82 | 1.58 | 0.79 | 0.45 | 0.92 | Upgrade |
Filing Date Shares Outstanding | 118.23 | 236.44 | 236.44 | 236.44 | 236.44 | 236.44 | Upgrade |
Total Common Shares Outstanding | 118.23 | 236.44 | 236.44 | 236.44 | 236.44 | 236.44 | Upgrade |
Working Capital | 34.57 | 17.06 | -0.97 | 36.38 | 52.7 | 207.64 | Upgrade |
Book Value Per Share | 4.01 | 1.95 | 1.85 | 1.75 | 1.72 | 1.64 | Upgrade |
Tangible Book Value | 474.57 | 460.4 | 436.46 | 414.82 | 405.77 | 387.46 | Upgrade |
Tangible Book Value Per Share | 4.01 | 1.95 | 1.85 | 1.75 | 1.72 | 1.64 | Upgrade |
Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.